Showing results (41-50 of 277) with videos related to

Sort By:
Pageof 28
Expert Opinion on Investigational Drugs|December 5, 2008
Development of PARP inhibitors in oncologyJordi Rodon, Maria D Iniesta, Kyriakos Papadopoulos
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Antiangiogenic tetrathiomolybdate protects against Her2/neu-induced breast carcinoma by hypoplastic remodeling of the mammary glandQuintin Pan, Devin T Rosenthal, Liwei Bao, et al.
Cancer Research|April 19, 2006
Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissuesLei Ding, Christine Erdmann, Arul M Chinnaiyan, et al.
Plos One|December 24, 2010
Multisite phosphorylation provides an effective and flexible mechanism for switch-like protein degradationS Marjan Varedi K, Alejandra C Ventura, Sofia D Merajver, et al.
Breast Cancer Research and Treatment|June 27, 2012
Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008Jennifer A Schlichting, Amr S Soliman, Catherine Schairer, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 30, 2016
Effects of postpartum mobile phone-based education on maternal and infant health in EcuadorJulie Maslowsky, Sara Frost, C Emily Hendrick, et al.
Molecular Cancer Therapeutics|July 29, 2003
Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinomaQuintin Pan, Li Wei Bao, Celina G Kleer, et al.
Molecular Cancer Therapeutics|March 17, 2007
Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancerBasil Hassouneh, Mozaffarul Islam, Thomas Nagel, et al.
Pageof 28